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Medicinal  plants  are  one  of the  most  important  sources  of  drugs  used  in  the  pharmaceutical  indus-
try.  Among  traditional  medicinal  plants,  Lippia  gracilis  Schauer  (Verbenaceae)  had  been used  for  several
medicinal  purposes  in Brazilian  northeastern.  In  this  study,  leaf  essential  oil  (EO)  of L. gracilis  was  pre-
pared  using  hydrodistillation.  Followed  by GC–MS  analysis,  its composition  was  characterized  by the
presence  of  thymol  (55.50%),  as  major  constituent.  The  effects  of  EO on cell  proliferation  and  apoptosis
induction  were  investigated  in HepG2  cells.  Furthermore,  mice  bearing  Sarcoma  180  tumor  cells  were
used  to  conﬁrm  its in  vivo  effectiveness.  EO  and  its constituents  (thymol,  p-cymene,  -terpinene  and
myrcene)  displayed  cytotoxicity  to  different  tumor  cell  lines.  EO  treatment  caused  G1 arrest  in  HepG2
cells  accompanied  by  the  induction  of  DNA  fragmentation  without  affecting  cell  membrane  integrity.
Cell  morphology  consistent  with  apoptosis  and a remarkable  activation  of  caspase-3  were  also  observed,
suggesting  induction  of caspase-dependent  apoptotic  cell  death.  In  vivo antitumor  study  showed  tumor
growth  inhibition  rates  of  38.5–41.9%.  In  conclusion,  the  tested  essential  oil  of  L.  gracilis  leaves,  which
has  thymol  as its  major  constituent,  possesses  signiﬁcant  in  vitro  and  in vivo  antitumor  activity.  These
entiadata  suggest  that  leaf  ess
ntroduction
Natural products are an interesting source of drugs used in the
harmaceutical industry. Among these, essential oils are complex
ixtures of odoriferous substances that usually present multiple
harmacology properties. Each of these constituents contributes
o the biological effects of these oils (Bakkali et al. 2008).
Lippia  gracilis Schauer (Verbenaceae), popularly known as
alecrim-da-chapada” and “candeia-de-queimar”, had been used
or several medicinal purposes in Brazilian northeastern. Among
ts folk medicinal uses, the treatment of cutaneous diseases,
urns, wounds, ulcers, inﬂuenza, cough, sinusitis, bronchitis, nasal
ongestion, headache, jaundice and paralysis have been reported
Pascual et al. 2001; Albuquerque et al. 2007). Usually, its leaves
re used to prepare infusion or decoction and used as a tea, as
ell as a macerate in alcohol for topical application (Lorenzi
nd Matos 2008). Some studies examining the pharmacological
∗ Corresponding author at: Department of Physiology, Federal University of
ergipe,  Av. Marechal Rondon, Jardim Rosa Elze, 49100-000 São Cristóvão, Sergipe,
razil. Tel.: +55 79 2105 6644.
E-mail  address: danielpbezerra@gmail.com (D.P. Bezerra).
944-7113 ©  2013  Elsevier  GmbH . 
ttp://dx.doi.org/10.1016/j.phymed.2013.01.015
Open access under the Elsevier OA license.l  oil of  L.  gracilis  is  a potential  medicinal  resource.
©  2013  Elsevier  GmbH.    
properties of L. gracilis have demonstrated that its leaf essential
oil presents antibacterial, molluscicidal, larvicidal, antinociceptive
and anti-inﬂammatory actions (Pessoa et al. 2005; Silva et al. 2008;
Mendes et al. 2010; Teles et al. 2010). The antinociceptive and
anti-inﬂammatory properties of methanolic extract of leaves of L.
gracilis have also been reported (Guimarães et al. 2012). Recently,
in our cytotoxic drug-screening program, we  demonstrated the
cytotoxic activity of leaf essential oil of L. gracilis to several
tumor cell lines (Ribeiro et al. 2012). However, the mechanisms
underlying these effects were not explored.
In present work, the chemical composition of leaf essential oil
(EO) of L. gracilis was characterized by CG–MS. The mechanisms
involved in EO cytotoxic activity were investigated in HepG2 cells.
In vivo effects of EO in mice bearing Sarcoma 180 tumor cells were
also evaluated.
Materials and methods
Open access under the Elsevier OA license.Cells
Cytotoxicity  was  determined in tumor cells using HepG2
(human hepatocellular carcinoma), K562 (human chronic
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Thymol p-Cymen e -Terpinene Myrcene
incorporation using a liquid scintillation cocktail Hidex Maxilight
(PerkinElmer Life Sciences, Groningen, GE, Netherlands) and a16 R.P.C. Ferraz et al. / Phyt
yelocytic leukemia) and B16-F10 (mouse melanoma), all
onated by Hospital A.C. Camargo, São Paulo, SP, Brazil. Cells were
aintained in Roswell Park Memorial Institute-1640 (RPMI-1640,
ibco-BRL, Gaithersburg, MD,  USA) medium supplemented with
0% fetal bovine serum (Cultilab, Campinas, SP, Brazil), 2 mM
-glutamine (Vetec Química Fina, Duque de Caxias, RJ, Brazil) and
0 g/ml gentamycin (Novafarma, Anápolis, GO, Brazil). Adherent
ells were harvested by treatment with 0.25% trypsin EDTA solution
Gibco-BRL, Gaithersburg, MD,  USA). All cell lines were cultured in
ell culture ﬂasks at 37 ◦C in 5% CO2 and sub-cultured every 3–4
ays to maintain exponential growth. Cytotoxicity experiments
ere conducted with cells in exponential growth phase.
Sarcoma 180 tumor cells, which had been maintained by pas-
ages in the peritoneal cavity of Swiss mice, were obtained from
he Laboratory of Experimental Oncology at the Federal University
f Ceará.
Human lymphocyte cells were obtained by primary culture.
eparinized blood (from healthy, non-smoker donors who had not
aken any drug at least 15 days prior to sampling) was collected
nd peripheral blood mononuclear cells (PBMC) were isolated by a
tandard protocol using Ficoll density gradient (Ficoll-Paque Plus,
E Healthcare Bio-Sciences AB, Sweden). PBMC were washed and
esuspended at a concentration of 0.3 × 106 cells/ml in RPMI 1640
edium supplemented with 20% fetal bovine serum, 2 mM glu-
amine, 50 g/ml gentamycin at 37 ◦C with 5% CO2. Concanavalin A
ConA, Sigma Chemical Co. St Louis, MO,  USA) was used as a mito-
en to trigger cell division in T-lymphocytes. ConA (10 g/ml) was
dded at the beginning of culture and after 24 h, cells were treated
ith the test drugs (Brown and Lawce 1997).
For all experiments, cell viability was performed by Trypan blue
ssay. Over 90% of the cells were viable at the beginning of the
ulture.
nimals
A total of 36 Swiss mice (males, 25–30 g), obtained from the cen-
ral animal house of the Federal University of Sergipe, Brazil, were
sed. Animals were housed in cages with free access to food and
ater. All animals were kept under a 12:12 h light-dark cycle (lights
n at 6:00 a.m.). Animals were treated according to the ethical prin-
iples for animal experimentation of SBCAL (Brazilian association of
aboratory animal science), Brazil. The Animal Studies Committee
rom the Federal University of Sergipe approved the experimental
rotocol (number 60/2010).
lant  material
L.  gracilis leaves were collected in the proximity of the “Serra
a Guia” [coordinates: 09◦58′09′ ′ S, 37◦51′52′ ′ W],  Poc¸ o Redondo,
ergipe State, Brazil in November 2006. Samples were processed
nd identiﬁed according to standard protocol (Mori et al. 1989),
eing deposited in the herbarium of the Federal University of
ergipe (ASE) under the number 18740. The specie was  identi-
ed by Dr. Raymond Mervyn Harley, Royal Botanic Gardens, Kew
England).
ydrodistillation and CG–MS analysis of the essential oil
The  essential oil from fresh leaves of L. gracilis (50 g) was
btained by hydrodistillation for 2 h using a Clevenger-type appa-
atus (Amitel, São Paulo, Brazil). The essential oil was  dried over
nhydrous sodium sulphate, and the percentage content was  calcu-
ated on the basis of the dry weight of plant material. The essential
il was stored at −4 ◦C in a sealed amber bottle until chemical
nalysis. The extractions were performed in triplicate.Fig. 1. Chemistry structure of thymol, p-cymene, -terpinene and myrcene.
Essential oil analysis of L. gracilis was  performed on a
Shimadzu QP5050A GC/MS system equipped with an AOC-
20i auto-injector. A J&W Scientiﬁc DB-5MS (coated with
5%-phenyl-95%-dimethylpolysiloxane) fused capillary column
(30 m × 0.25 mm × 0.25 m ﬁlm thickness) was  used as the sta-
tionary phase. Helium was  the carrier gas at 1.2 ml/min ﬂow rate.
Column temperatures were programmed from 40 ◦C for 4 min,
raised to 220 ◦C at 4 ◦C/min, and then heated to 240 ◦C at 20 ◦C/min.
The injector and detector temperatures were 250 and 280 ◦C,
respectively. Samples (0.5 l in CH2Cl2) were injected with a 1:20
split ratio. MS  were taken at 70 eV with a scan interval of 0.5 s and
fragments from 40–350 Da.
The retention indices were obtained by co-injecting the oil sam-
ple with a C8–C18 linear hydrocarbon mixture (van Den Dool and
Kratz 1963). The volatile components were analyzed by GC/MS, and
identiﬁcation was  made by comparing retention indices and mass
spectra with those in the literature (Adams 2007), as well as by com-
puterized matching of the acquired mass spectra with those stored
in the NIST and Wiley mass spectral library and other published
mass spectra. The percentage composition of each component was
determined by dividing the area of the component by the total area
of all components isolated under these conditions without response
factor correction.
Pure  compounds
Thymol (purity ≥99.5%), p-cymene (purity 99%), -terpinene
(purity ≥97.0%) and myrcene (purity ≥90%) (Fig. 1) were obtained
from Sigma Chemical Co. St Louis, MO,  USA.
Cell proliferation assay
Cell  growth was quantiﬁed by methyl-[3H]-thymidine incorpo-
ration assay, as described by Grifﬁths and Sundaram (2011) with
minor modiﬁcations. Methyl-[3H]-thymidine is a radiolabelled
DNA precursor incorporated into newly synthesized DNA, which
the amount of incorporated methyl-[3H]-thymidine is related to
the rate of proliferation. For all experiments, 100 l of a solu-
tion of cells (0.7 × 105 cells/ml for adherent cells or 0.3 × 106
cells/ml for suspended cells) were seeded in 96-well plates. After
24 h, the drugs (1.56–50 g/ml), dissolved in dimethyl sulfoxide
(DMSO, LGC Biotechnology, São Paulo, SP, Brazil), was added to each
well and incubated for 72 h. Doxorubicin (doxorubicin hydrochlo-
ride, Eurofarma, São Paulo, SP) was  used as the positive control.
Six hours before the end of incubation time, 1 Ci of methyl-
[3H]-thymidine (PerkinElmer, USA) was added to each well. After
this period, cultures were harvested using a cell harvester (Bran-
del, Inc. Gaithersburg, MD,  USA) to determine the 3H-thymidineplate CHAMELEON V multilabel Counter (Mustionkatu 2, TURKU,
Finland) with MikroWin Hidex 2000 v. 4.38 software (Microtek
Laborsysteme GmbH, Overath, Germany). The drug effect was
quantiﬁed as the percentage of control radioactivity.
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nalysis of mechanisms involved in the cytotoxic activity
The  following experiments were performed to elucidate the
echanisms involved in cytotoxic action of EO. For all experiments,
 ml  of a solution of HepG2 cells (0.7 × 105 cells/ml) were seeded
n 24-well plates and incubated by overnight to allow that the cells
o adhere to the plate surface. Then, the cells were treated for 24 h
ith EO at ﬁnal concentration of 2.5 and 5.0 g/ml. Negative con-
rol was treated with the vehicle (0.1% DMSO) used for diluting
he tested drug. Doxorubicin (1.0 g/ml) was used as the positive
ontrol.
rypan blue dye exclusion test
Cell proliferation was  assessed by the Trypan blue dye exclusion
est. HepG2 cells were seeded in the absence and presence of EO.
fter 24 h drug exposure, cell proliferation was assessed. Cells that
xcluded Trypan blue were counted using a Neubauer chamber.
ell  cycle distribution
Cells  were harvested in a lysis solution containing 0.1% Triton
-100 (Sigma Chemical Co. St Louis, MO,  USA) and 2 g/ml pro-
idium iodide (BioSource, USA). Cell ﬂuorescence was  determined
y ﬂow cytometry in a FACSCalibur cytometer (Bencton Dickinson,
an Diego, CA, USA) with CellQuest software (BD Biosciences, San
ose, CA, EUA). Ten thousand events were evaluated per experiment
nd cellular debris was omitted from the analysis.
orphological analysis with hematoxylin–eosin staining
Morphological changes were examined by light microscopy
Olympus BX41, Tokyo, Japan) using Image-Pro Express software
Media Cybernetics, Inc. Silver Spring, USA). To evaluate alterations
n morphology, cells from cultures were harvested, transferred to
ytospin slides, ﬁxed with methanol for 30 s, and stained with
ematoxylin–eosin.
orphological analysis using ﬂuorescence microscope
Morphological changes were examined using ﬂuorescence
icroscope. Cells were pelleted and resuspended in 25 l saline.
hereafter, 1 l of aqueous solution of acridine orange (AO, Sigma
hemical Co. St Louis, MO,  USA) and ethidium bromide (EB, Sigma
hemical Co. St Louis, MO,  USA) (AO/EB, 100 g/ml) was added and
he cells were observed under a ﬂuorescence microscope (Olympus
X41, Tokyo, Japan). Three hundred cells were counted per sample
nd classiﬁed as viable, apoptotic or necrotic cells.
ell membrane integrity
The  cell membrane integrity was evaluated by the exclusion
f propidium iodide. Cell ﬂuorescence was determined by ﬂow
ytometry, as described above.
aspase-3 activation assay
Caspase-3/CPP32  colorimetric assay kit (BioVision Incorpo-
ated, CA, USA) was used to investigate caspase-3 activation in
reated cells based on the cleavage of Asp-Glu-Val-Asp (DEVD)-
NA. Brieﬂy, cells were lysed by incubation with cell lysis buffer on
ce for 10 min  and then centrifuged at 10,000 g for 1 min. To each
eaction mixture, 50 l cell lysate (100–200 g total protein) was
dded. Enzyme reactions were carried out in a 96-well ﬂat-bottom
icroplate.cine 20 (2013) 615– 621 617
In vivo antitumor assay
The  in vivo antitumor effect was  evaluated using sarcoma
180 ascites tumor cells following protocols previously described
(Bezerra et al. 2008; Britto et al. 2012). Ten-day old sarcoma 180
ascites tumor cells (2 × 106 cells per 500 l) were implanted sub-
cutaneously into the left hind groin of mice. EO was dissolved in 5%
DMSO and given to mice intraperitoneally once a day for 7 consecu-
tive days. Negative control was treated with the vehicle (5% DMSO)
used for diluting the tested substance. 5-Fluoruoracil (5-FU, Sigma
Chemical Co. St Louis, MO,  USA) was  used as the positive control.
At the beginning of the experiment, the mice were divided into
four groups, as follows: Group 1: animals treated by i.p. injection
of vehicle 5% DMSO (n = 12); Group 2: animals treated by i.p. injec-
tion of 5-FU (25 mg/kg/day) (n = 8); Group 3: animals treated by
i.p. injection of EO (40 mg/kg/day) (n = 8); Group 4: animals treated
by i.p. injection of EO (80 mg/kg/day) (n = 8). The treatments were
started one day after tumor injection. The dosages were determined
based on previous articles. On day 8, the animals were euthanized,
by cervical dislocation, and the tumors were excised and weighed.
The drug effects were expressed as the percent inhibition of control.
Body weight loss, organ weight alteration and hematological
analyses were determined at the end of experiment above, as pre-
viously described (Bezerra et al. 2008; Britto et al. 2012). Peripheral
blood samples were collected from the retro-orbital plexus under
light ether anesthesia and the animals were euthanized by cervical
dislocation. After sacriﬁce, liver, kidney and spleens were removed
and weighed. In hematological analysis, total and differential leuko-
cyte counts were determined by standard manual procedures using
light microscopy.
Statistical analysis
Data  are presented as mean ± SEM (or SD) or IC50 values and
their 95% conﬁdence intervals (CI 95%) obtained by nonlinear
regression. Differences among experimental groups were com-
pared by one-way analysis of variance (ANOVA) followed by
Newman–Keuls test (p < 0.05). All analyses were carried out using
the GRAPHPAD program (Intuitive Software for Science, San Diego,
CA, USA).
Results and discussion
The  present work investigated the phytochemical and cytotoxic
properties of leaf essential oil of L. gracilis. It was chemically char-
acterized by CG–MS analysis. The effects of EO on cell proliferation
and apoptosis induction were investigated in HepG2 cells. Further-
more, mice bearing Sarcoma 180 tumor cells were used to conﬁrm
its in vivo effectiveness.
EO  was  obtained as pale yellowish oil in 4.0% yield (w/v). Pre-
vious reports on essential oil composition of L. gracilis growing
in Brazil, particularly in Ceará, Pernambuco and Sergipe States
showed monoterpenes mainly p-cymene, -terpinene and variable
content of carvacrol and/or thymol as its major components (Pessoa
et al. 2005; Silva et al. 2008; Neves et al. 2008; Mendes et al. 2010;
Teles et al. 2010). In the present study, it was  possible to identify 35
compounds in the leaf essential oil of L. gracilis that was  also con-
stituted predominantly by monoterpenes (Table 1). However, due
to the higher percentage of thymol and the presence of other major
components identiﬁed such as p-cymene, thymol methyl ether, -
terpinene, myrcene and thymol acetate, the chemical composition
of this specimen is different from others collected in Sergipe and
in others Brazilian localities (Pessoa et al. 2005; Silva et al. 2008;
Neves et al. 2008; Mendes et al. 2010; Teles et al. 2010). Moreover,
618 R.P.C. Ferraz et al. / Phytomedicine 20 (2013) 615– 621
Table  1
Chemical constituents of leaf essential oil of L. gracilis.
RIa RIb Compounds % Peak areac
1 884 880 3-Methyl-3-buten-1-ol acetate tr
2 924 924 -Thujene 1.23 ± 0.12
3 930  932 -Pinene 0.40 ± 0.00
4 973 974 -Pinene tr
5 988  988 Myrcene 4.03 ± 0.29
6 1003 1002 -Phellandrene 0.10 ± 0.00
7 1005 1008 -3-Carene 0.27 ± 0.06
8 1014 1014 -Terpinene 1.47 ± 0.15
9 1022 1020 p-Cymene 10.80 ± 1.35
10 1026 1024 Limonene 0.57 ± 0.06
11 1035  1032 (Z)--Ocimene 0.20 ± 0.00
12 1045 1044 (E)--Ocimene 0.20 ± 0.00
13 1056 1054 -Terpinene 5.53 ± 0.57
14 1067 1065 cis-Sabinene hydrate tr
15 1082  1086 Terpinolene 0.10 ± 0.00
16 1097  1095 Linalool 0.13 ± 0.06
17 1169 1167 Umbellulone 0.30 ± 0.18
18 1176 1174 Terpinen-4-ol 0.90 ± 0.00
19 1226 1232 Thymol methyl ether 10.53 ± 1.40
20 1290  1289 Thymol 55.50 ± 4.21
21 1294 1298 Carvacrol 0.20 ± 0.00
22 1343 1349 Thymol acetate 3.30 ± 0.44
23 1362 1369 Cyclosativene 0.20 ± 0.00
24 1369 1374 -Copaene 0.10 ± 0.00
25 1377 1376 (E)-Methyl  cinnamate 0.30 ± 0.10
26 1416 1417 (E)-Caryophyllene 1.43 ± 0.06
27 1435  1439 Aromadendrene 0.20 ± 0.00
28 1452 1452 -Humulene 0.20 ± 0.00
29 1469 1469d 2,6-Dimethoxyacetophenone 0.23 ± 0.06
30 1487 1496 Viridiﬂorene 0.20 ± 0.00
31 1491 1500 Bicyclogermacrene 0.17 ± 0.06
32 1504 1505  -Bisabolene 0.27 ± 0.06
33 1511 1511 -Amorphene tr
34 1578  1582 Caryophyllene oxide 0.20 ± 0.00
35 1581 1590 Globulol 0.10 ± 0.01
TOTAL 99.36
tr, trace (mean value < 0.10%).
a RI, retention indices on DB-5MS column calculated according to van Den Dool
and  Kratz (1963).
b RI, retention indices according to Adams (2007).
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d RI, retention index according to Tret’yakov (2008).
he lowest content of carvacrol and (E)-caryophyllene suggests that
his may  be another chemotype that it is a novel source of thymol.
Three tumor cell lines were treated with increasing concentra-
ions of EO and its constituents (thymol, p-cymene, -terpinene
nd myrcene) for 72 h and analyzed by methyl-[3H]-thymidine
ncorporation assay. Table 2 shows the obtained IC50 values. EO
howed IC50 values ranged from 4.93 to 22.92 g/ml for HepG2
nd K562 cell lines, respectively. Among its constituents, myrcene
resented to be the most cytotoxic compound, showing IC50 values
anging from 9.23 to 12.27 g/ml for HepG2 and B16-F10 cell lines,
espectively. Thymol, p-cymene and -terpinene showed cytotox-
city only for B16-F10, showing IC50 values of 18.23, 20.06 and
.28 g/ml, respectively. Doxorubicin, used as the positive con-
rol, showed IC50 values from 0.03 to 2.92 g/ml for B16-F10 and
562 cell lines, respectively. In addition, the cytotoxicity of EO was
lso evaluated to normal cells (PBMC). The results, presented in
able 2, show that EO was also cytotoxic to normal cells. None of
O constituents showed cytotoxicity to normal cells at the tested
oncentrations (IC50 > 25 g/ml).
According to our cytotoxic drug-screening program, essential
il that shows IC50 values below 30 g/ml and pure compound
hat shows IC50 values below 1 g/ml are considered promising
Suffness and Pezzuto 1990; Bezerra et al. 2008). Therefore, EO
s considered a potent cytotoxic agent. On the other hand, its
onstituents thymol, p-cymene, -terpinene and myrcene are con-
idered weak cytotoxic agents. These compounds were previously Ta
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Table  3
Effect of leaf essential oil of L. gracilis on cell cycle distribution of human hepatocellular carcinoma HepG2 cells after 24 h incubation.
Drugs Concentration
(g/ml)
Cell  cycle phases (%)
G1 S G2/M
Control – 62.49 ± 2.12 10.76 ± 1.57 17.63 ± 1.86
Doxorubicin 1.0 39.31 ± 5.06* 9.64 ±  1.73 54.07 ±  7.90*
Essential oil 2.5 72.08 ± 1.10* 9.23 ± 1.32 13.26 ± 0.88
5.0 74.61 ± 1.31* 8.87 ± 0.85 12.48 ± 0.78
D forme
d usand
st.
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T
t
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pathway  to maintain tissue homeostasis and eliminate the mutated
neoplastic and hyperproliferating neoplastic cells from the system
(Pucci et al. 2000). Besides the increasing of cells in G1, it was  also
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Fig. 2. Effect of leaf essential oil of L. gracilis on the proliferation of human hepa-
tocellular  carcinoma HepG2 cells measured by Trypan blue dye exclusion method
F
b
uata are presented as mean values ± S.E.M. from two independent experiments per
iluting  the tested substance. Doxorubicin was used as the positive control. Ten tho
* p < 0.05 compared to control by ANOVA followed by Student-Newman–Keuls te
ssessed against tumor cell lines. Among them, thymol showed
C50 value of ∼60 g/ml to HL-60 cells and -terpinene showed
C50 value of 156.92 g/ml to Jurkat cells (Deb et al. 2011; Döll-
oscardin et al. 2012). Probably, the potent cytotoxic activity of
ested essential oil might be attributed to mixture of its main and
inor constituents.
Since  HepG2 cells were especially sensitive to EO cytotoxicity,
urther studies were performed with this cell line using concen-
rations corresponding to 2.5 and 5.0 g/ml. These concentrations
ere chosen based on its IC50 value in this cell line (4.93 g/ml).
When analyzed by Trypan blue dye exclusion, EO reduced prolif-
ration of HepG2 cells in a concentration-dependent manner after
4 h incubation (p < 0.05, Fig. 2).
Cell cycle arrest is a common cause of cell growth inhibition. To
etermine whether EO cytotoxicity induction involves alterations
n cell cycle progression, analysis of cell cycle distribution by ﬂow
ytometry were included in this study. All DNA subdiploid in size
sub-G1) were considered as internucleosomal DNA fragmentation.
he results of the effect of EO on cell cycle distribution showed
hat total number of G1 cells increased, indicating cell cycle arrest
uring this phase (Table 3). G1-phase cell cycle arrest creates an
pportunity for cells to either undergo repair or enter the apoptotic
ig. 3. Effect of leaf essential oil of L. gracilis on cell morphology of human hepatocellular c
y  optical microscopy after 24 h incubation with the essential oil at concentrations 2.5 (C
sed for diluting the tested substance. Doxorubicin (1.0 g/ml) was  used as the positive cond in duplicate. Negative control was treated with the vehicle (0.1% DMSO) used for
 events were analyzed in each experiment.after  24 h incubation. Negative control was treated with the vehicle (0.1% DMSO)
used  for diluting the tested substance. Doxorubicin (Dox, 1.0 g/ml) was used as
the positive control. Data are presented as mean values ± S.E.M. from two or three
independent experiments performed in duplicate. *p < 0.05 compared to negative
control  by ANOVA followed by Student-Newman–Keuls test.
arcinoma HepG2 cells. The cells were stained with hematoxylin-eosin and analyzed
) and 5.0 (D) g/ml. Negative control (A) was treated with the vehicle (0.1% DMSO)
trol (B). Black arrows show chromatin condensation or nuclear DNA fragmentation.
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Fig. 4. Effect of leaf essential oil of L. gracilis on viability of human hepatocellular carcinoma HepG2 cells after 24 h incubation. (A) Cell viability measured by ﬂuorescence
microscope using acridine orange/ethidium bromide – viable cells (white bar), apoptotic cell (gray bar), necrotic cell (black bar). (B) Cell membrane integrity measured by
ﬂow  cytometry using propidium iodide. (C) Internucleosomal DNA fragmentation determined by ﬂow cytometric using propidium iodide and triton X-100. (D) Caspase 3
activation  measured by colorimetric assay. Negative control was  treated with the vehicle (0.1% DMSO) used for diluting the tested substance. Doxorubicin (Dox, 1.0 g/ml)
w o  or t
t tive c
o
(
h
c
c
o
i
w
c
i
(
(
t
m
a
f
d
n
p
p
f
b
d
d
e
i
c
o
H
p
t
s
eters analyzed (p > 0.05, data not shown). In contrast, 5-FU, used as
the positive control, reduced the body weights and spleen organ
weights and induced a decrease in total leukocytes (p < 0.05, data
not shown).
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Fig. 5. Effect of leaf essential oil of L. gracilis on mice inoculated with sarcoma
180  tumor. The graph shows tumor weight (g) and tumor growth-inhibitionas  used as the positive control. Data are presented as mean values ± S.E.M. from tw
en  thousand events were analyzed in each experiment. *p < 0.05 compared to nega
bserved an increasing in the internucleosomal DNA fragmentation
p < 0.05, Fig. 4C).
Morphological changes were investigated using
ematoxylin–eosin staining (Fig. 3). In presence of 5.0 g/ml of EO,
ells presented morphology consistent with apoptosis, including
ell volume reduction, chromatin condensation and fragmentation
f the nuclei condensation. Morphological changes were also
nvestigated using AO/EB staining and ﬂuorescence microscopy,
here the percentages of viable, apoptotic and necrotic cells were
alculated. After 24 h of exposure, EO-treated cells presented an
ncreased number of apoptotic cells at concentration of 5 g/ml
p < 0.05, Fig. 4A).
EO did not disrupt membrane at any tested concentration
p > 0.05, Fig. 4B). In addition, as cited above, DNA fragmenta-
ion increased in EO-treated cells (p < 0.05, Fig. 4C). These both
odiﬁcations were compatible with apoptotic cells. In addition,
 remarkable activation of caspase-3 was recorded in lysates
rom HepG2 cells treated with EO (Fig. 4D), suggesting caspase-
ependent apoptotic cell death.
Apoptosis is a regulated cell death process that elimi-
ates damaged or malfunctioning cells. It is characterized by
hosphatidylserine exposure, loss of mitochondrial membrane
otential, caspase activation, chromatin condensation, nuclear
ragmentation, resulting in the phagocytosis of membrane-
ound apoptotic bodies (Walsh and Edinger 2010). Herein, we
emonstrated that EO is able to induce cell death through caspase-
ependent apoptosis pathway in HepG2 cells. Interestingly, Deb
t al. (2011) reported that thymol, the main constituent of EO,
s able to induce HL-60 cell death by apoptosis pathway asso-
iated with the reactive oxygen species production, disruption
f mitochondrial membrane potential, increase in mitochondrial
2O2 production, a decrease in Bcl-2 protein, an increase in Bax
rotein levels and caspase-9, -8 and -3 activation. Moreover,
hymol was also able to induce caspase-independent apopto-
is.hree independent experiments performed in duplicate. For ﬂow cytometry analysis
ontrol by ANOVA followed by Student-Newman–Keuls test.
To investigate whether OE has in vivo antitumor activity, mice
were subcutaneously transplanted with sarcoma 180 cells and
treated by intraperitoneal route once a day for 7 consecutive days
with EO. The effects of EO on mice transplanted with sarcoma 180
tumor cells are presented in Fig. 5. Tumor growth inhibition rates
were 38.5–41.9%. The inhibition was signiﬁcant at both doses in
relation to the control group (p < 0.05).
Systemic  toxicological parameters were also examined in
EO-treated mice. For these, body weight loss, organ weight alter-
ation and leukogram were determined. No statistically signiﬁcant
changes in EO-treated mice were seen in any toxicological param-levels.  Negative control was  treated with the vehicle used for diluting the test
substance (5% DMSO). 5-Fluorouracil (5-FU) was used as the positive control
at  dose of 25 mg/kg/day. Data are presented as mean ± S.E.M. of 8–12 animals.
*p  < 0.05 compared with negative control group by ANOVA followed by the Student-
Newman–Keuls  test.
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In conclusion, these data presented that the tested leaf essen-
ial oil of L. gracilis is chemically characterized by the presence of
hymol, as major constituent, and possesses in vitro and in vivo anti-
ancer activities. In cell-based assay, it was able to induce G1 arrest
nd caspase-dependent apoptosis in HepG2 cells. In animal model,
t was found to be associated with a decrease in tumor growth.
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